RecruitingEarly Phase 1NCT04469842
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
Studying Complication after organ transplantation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Anil J Trindade, MD, MDVanderbilt University Medical Center
- Intervention
- Tacrolimus Extended Release Oral Tablet [Envarsus](drug)
- Enrollment
- 48 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Collaborators
Veloxis Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04469842 on ClinicalTrials.govOther trials for Complication after organ transplantation
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06872333Allo HSCT for High Risk HemoglobinopathiesMasonic Cancer Center, University of Minnesota
- RECRUITINGNANCT06512545Modified Second Haplo-transplantation for Graft FailurePeking University People's Hospital
- RECRUITINGNANCT06512519Second Haplo-transplantation for Graft FailurePeking University People's Hospital
- RECRUITINGNCT05836922Association Between Renal Regional Oxygen Saturation Measured by Near-InfraRed Spectroscopy and Postoperative Renal Failure After Lung Transplantation Surgery: A Pilot StudyAssistance Publique Hopitaux De Marseille
- RECRUITINGNANCT06386198HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant RecipientsUniversity of California, San Francisco
- ENROLLING BY INVITATIONNCT05818644Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in ChildrenUniversity Medical Center Groningen
- ACTIVE NOT RECRUITINGPHASE4NCT05557370Immunogenicity of HPV Vaccine in Transplant Recipients.Medical College of Wisconsin
- ENROLLING BY INVITATIONPHASE2NCT05285878Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney TransplantationThe Methodist Hospital Research Institute
See all trials for Complication after organ transplantation →